Next Article in Journal / Special Issue
Molecular Genetic Markers in Acute Myeloid Leukemia
Previous Article in Journal
Small Drusen and Age-Related Macular Degeneration: The Beaver Dam Eye Study
Previous Article in Special Issue
Pediatric AML: From Biology to Clinical Management
Article Menu

Export Article

Open AccessReview
J. Clin. Med. 2015, 4(3), 441-459; doi:10.3390/jcm4030441

Treatment of Acute Myeloid Leukemia in Adolescent and Young Adult Patients

Department of Hematology, Ankara University School of Medicine, Ankara 06100, Turkey
*
Author to whom correspondence should be addressed.
Academic Editor: Celalettin Ustun
Received: 5 September 2014 / Accepted: 3 February 2015 / Published: 11 March 2015
(This article belongs to the Special Issue AML in the Molecular Age: From Biology to Clinical Management)
View Full-Text   |   Download PDF [154 KB, uploaded 11 March 2015]

Abstract

The objectives of this review were to discuss standard and investigational treatment strategies for adolescent and young adult with acute myeloid leukemia, excluding acute promyelocytic leukemia. Acute myeloid leukemia (AML) in adolescent and young adult patients (AYAs) may need a different type of therapy than those currently used in children and older patients. As soon as AML is diagnosed, AYA patient should be offered to participate in well-designed clinical trials. The standard treatment approach for AYAs with AML is remission induction chemotherapy with an anthracycline/cytarabine combination, followed by either consolidation chemotherapy or stem cell transplantation, depending on the ability of the patient to tolerate intensive treatment and cytogenetic features. Presently, continuing progress of novel drugs targeting specific pathways in acute leukemia may bring AML treatment into a new era. View Full-Text
Keywords: acute myeloid leukemia; adolescent and young adults; treatment acute myeloid leukemia; adolescent and young adults; treatment
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Seval, G.C.; Ozcan, M. Treatment of Acute Myeloid Leukemia in Adolescent and Young Adult Patients. J. Clin. Med. 2015, 4, 441-459.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top